CClinicalTrials.gg
CompletedNCT06938672Updated May 7, 2026

Evaluating the Effects of tDCS on Sleep and Cognition in Healthy Older Adults

An interventional study of Placebo Transcranial Direct Current Stimulation (tDCS) and Active Transcranial Direct Current Stimulation (tDCS) in Sleep, Cognition and Healthy Aging, sponsored by Northumbria University. Completed at 1 site in United Kingdom. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Northumbria University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The goal of this interventional study is to learn if transcranial direct current stimulation (tDCS), a gentle, cost-effective and non-invasive brain stimulation technique can improve sleep brain activity during an afternoon nap. Since these sleep brain patterns are linked to better memory, attention, and thinking skills, this study aims to find out if improving sleep in a nap can also enhance these cognitive skills in healthy older adults (aged 60+).

The main questions it aims to answer are:

  • Can a short (20-minute) tDCS session before a nap improve sleep patterns during the nap?
  • Since these sleep patterns are linked to memory and attention, can tDCS also improve thinking skills after the nap?
  • Are two tDCS session more effective than one for improving nap sleep and thinking skills?

Participants will:

  • Be required to come to the university for testing over four days.

During each session they will:

  • Complete computer based-tasks to assess memory and thinking.
  • Receive a 20-minute session of either real (active) or fake (placebo) tDCS.
  • Take a short, monitored nap while researchers measure sleep activity (using polysomnography - a gold-standard, non-invasive sleep monitoring tool).
  • Complete an easy-to-use sleep test at home on the nights after the naps.

    • Wear a lightweight watch (called an Actiwatch) throughout the study period to track sleep and movement.
    • Complete daily sleep diaries.

By taking part, participants will help researchers understand whether tDCS can improve sleep during naps and, in turn, support memory and thinking skills. This research could lead to better treatments for sleep problems, help protect brain health, and reduce the risk of dementia as people age. The brain stimulation in this study may also help improve their sleep and cognition.

Read the detailed description

Sleep is vital for maintaining physical and cognitive health across the lifespan. However, normal age-related changes to sleep can impair memory, learning, and waste clearance in the brain, contributing to the risk of cognitive decline and dementia.

Transcranial direct current stimulation (tDCS), a non-invasive technique that modulates brain activity, shows promise for enhancing both sleep and cognition. However, existing studies have significant methodological limitations. Notably, very few have investigated 'offline' tDCS -where stimulation is applied before sleep- to assess objective sleep changes using polysomnography (PSG). Instead, most research has relied on subjective measures, consistently finding that offline tDCS enhances perceived sleep quality, especially with repeated stimulation sessions. Importantly, offline tDCS may be more feasible for use outside laboratory settings compared to 'online' approaches, where stimulation is applied during sleep, making it a more scalable intervention.

Furthermore, delivering tDCS before a daytime nap, rather than nocturnal sleep, offers additional advantages by reducing participant burden, particularly in older adults. Studies applying tDCS during a nap in older adults have shown improvements in objective sleep microstructure and declarative memory. By contrast, studies applying tDCS during nocturnal sleep have reported inconsistent results. Despite its potential benefits, no studies have explored the effects of an offline, nap-based tDCS approach on objective sleep outcomes.

Additionally, few studies have examined whether repeated sessions of offline tDCS might amplify its effects on objective PSG-measured sleep. While repeated sessions have been shown to positively influence subjective sleep outcomes, it remains unclear whether the same benefits apply to objective sleep metrics. This study will address this gap by investigating whether two sessions of offline tDCS, compared to one, are necessary to improve objective sleep outcomes.

In summary, this study aims to determine whether offline tDCS applied prior to a nap can enhance objective sleep during a daytime nap and improve post-nap cognitive performance in older adults. If effective, this low-burden, non-invasive intervention could serve as a practical tool for promoting healthy aging and reducing dementia risk.

The primary objectives of this randomised, placebo-controlled crossover trial are:

To evaluate the impact of offline tDCS on objective sleep microstructure and architecture during naps.

To assess the effects of tDCS on post-nap cognitive performance. To examine the cumulative effect of two tDCS sessions upon objective sleep and cognition, compared to one.

02

Conditions studied

  • Sleep
  • Cognition
  • Healthy Aging

Keywords

  • sleep
  • healthy aging
  • cognition
  • tDCS
  • non-invasive brain stimulation
  • nap
03

In context

Lead sponsor

Northumbria University is the lead sponsor of 156 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 60+ years
  • Speak fluent English
  • Be cognitively healthy
  • A self-reported good sleeper, with a regular sleep pattern

Exclusion criteria

Exclusion Criteria:

  • The presence of any major physical or psychiatric illness or comorbidities
  • Self-reported neurodegenerative dementia or other neurological disorders
  • Self-reported relevant sleep disorders or disturbances
  • Those with irregular sleep schedules (i.e. night shift workers)
  • A PSQI score above 5 (as this is associated with significant sleep disturbance)
  • Relevant skin allergies
  • Taking medication that affects the central nervous system or sleep, or consume caffeine, alcohol or cigarettes excessively
  • Metallic or electronic implants
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
12 participants (actual)

Study arms

  • Active comparator
    Active Transcranial Direct Current Stimulation (tDCS)

    Transcranial direct current stimulation. Participants will experience a 20-minute session of active tDCS (1.2 mA) on two consecutive days.

    Device: Active Transcranial Direct Current Stimulation (tDCS)

  • Placebo comparator
    Placebo Transcranial Direct Current Stimulation (tDCS)

    Transcranial direct current stimulation. Participants will experience a 20-minute session of placebo tDCS on two consecutive days.

    Device: Placebo Transcranial Direct Current Stimulation (tDCS)

Interventions

  • DevicePlacebo Transcranial Direct Current Stimulation (tDCS)

    Placebo Transcranial direct current stimulation (tDCS): Participants will experience a 20-minute session of placebo tDCS on two consecutive days.

    Also known as: sham tDCS

  • DeviceActive Transcranial Direct Current Stimulation (tDCS)

    Active transcranial direct current stimulation (tDCS). Participants will experience a 20-minute session of active tDCS (1.2 mA) on two consecutive days.

    Also known as: tDCS

06

What researchers measure

Primary outcomes

  1. Sleep spindle density

    PSG-measured slow (11.99 - 12.99Hz) and fast (13 - 14.99Hz) sleep spindle density

    Time frame: During nap immediately after tDCS application

  2. Sleep spindle amplitude

    PSG-measured slow (11.99 - 12.99Hz) and fast (13 - 14.99Hz) sleep spindle amplitude

    Time frame: During nap immediately after tDCS application

  3. Slow wave sleep amplitude

    PSG-measured SWS amplitude (peak-to-peak, μV)

    Time frame: During nap immediately after tDCS application

  4. Slow wave sleep density

    PSG-measured slow wave sleep density (number of slow waves divided by the minutes of sleep)

    Time frame: During nap immediately after tDCS application

  5. Verbal declarative memory

    Change in Verbal Paired Associates Word Learning Task performance will be measured by % correct recall at baseline (before the tDCS intervention and nap) compared to % correct recall 15 minutes after the nap has taken place.

    Time frame: Baseline (before tDCS/nap) and 15 minutes after the nap

  6. Attentional Network Task (ANT)

    Change in Attentional Network Task performance will be measured by Reaction Time (RT) (Milliseconds (ms) at baseline (before the tDCS intervention and nap) compared to RT (ms) 15 minutes after the nap has taken place.

    Time frame: Baseline (before tDCS/nap) and 15 minutes after the nap

  7. Attentional Network Task (ANT)

    Change in Attentional Network Task performance will be measured by Accuracy (%) at baseline (before the tDCS intervention and nap) compared to Accuracy (%) 15 minutes after the nap has taken place.

    Time frame: Baseline (before tDCS/nap) and 15 minutes after the nap

Secondary outcomes

  1. Visuo-spatial declarative picture memory

    Change in Picture Memory performance will be measured by Accuracy (% Correct) at baseline (before the tDCS intervention and nap) compared to Accuracy (% Correct) 15 minutes after the nap has taken place.

    Time frame: Baseline (before tDCS/nap) and 15 minutes after the nap

  2. Visuo-spatial declarative location memory

    Change in Location Memory performance will be measured by Accuracy (% Correct) at baseline (before the tDCS intervention and nap) compared to Accuracy (% Correct) 15 minutes after the nap has taken place

    Time frame: Baseline (before tDCS/nap) and 15 minutes after the nap

07

Study locations

1 site
  • Northumbria University
    Newcastle upon Tyne, NE1 8ST, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06938672
Lead sponsor
Northumbria University
Responsible party
Sponsor
First posted
Apr 22, 2025
Start date
Jul 1, 2025
Primary completion
May 6, 2026
Completion
May 6, 2026
Last update
May 7, 2026

Study contacts

Rosie H Musgrave, BA Hons, RPSGT
principal investigator · Northumbria University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion